Cornercap Investment Counsel’s Zimmer Biomet ZBH Stock Holding History

Cornercap Investment Counsel’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-8,243	Closed	-$925K	–	659
2023 Q3	$925K	Buy	+8,243	New	+$1.05M	0.17%	244
2023 Q1	–	Sell	-8,438	Closed	-$1.08M	–	661
2022 Q4	$1.08M	Buy	+8,438	New	+$979K	0.19%	179
2021 Q4	–	Sell	-14,861	Closed	-$2.11M	–	623
2021 Q3	$2.11M	Buy	+14,861	New	+$2.19M	0.24%	100
2017 Q1	–	Sell	-29,582	Closed	-$2.96M	–	396
2016 Q4	$2.96M	Buy	+29,582	New	+$3.17M	0.51%	66

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cornercap Investment Counsel's ZBH Position: Q4 2023 in Review

Cornercap Investment Counsel sold out of Zimmer Biomet (ZBH) in Q4 2023, closing a stake of 8,243 shares — an estimated $925K sold.

Cornercap Investment Counsel first reported a position in ZBH in Q4 2016 and held it in 4 quarters. The position peaked at $2.96M in Q4 2016. 1,030 funds tracked by Wall St. Rank hold ZBH as of Q4 2023.

Cornercap Investment Counsel reported no remaining Zimmer Biomet position as of Q4 2023 after selling out during the quarter.
Cornercap Investment Counsel sold 8,243 Zimmer Biomet shares in Q4 2023, an estimated $925K.
Cornercap Investment Counsel first reported a position in Zimmer Biomet in Q4 2016 and held it in 4 quarters.
Cornercap Investment Counsel's Zimmer Biomet position peaked at $2.96M in Q4 2016.
1,030 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2023.

Based on Cornercap Investment Counsel's 13F filing for Q4 2023, filed 30 Jan 2024.